Literature DB >> 10560127

Bone mineral density and vitamin D in patients with sarcoidosis.

K Hamada1, S Nagai, T Tsutsumi, T Izumi.   

Abstract

BACKGROUND AND AIM OF THE WORK: Imbalance of calcium homeostasis has ben frequently detected in sarcoidosis patients. In our previous study abnormal metabolism of calcium was detected in about 40% of the patients. In the current study, bone mineral density (BMD) was investigated in relation to serum concentration of calcium and vitamin D.
METHODS: Consecutive groups of fifteen men (40 +/- 12 years, as mean +/- SD) and 18 women (51 +/- 11 years) with histologically proven sarcoidosis who had not been treated with corticosteroids prior to the study were studied together with control groups. BMD was measured with dual-energy X-ray absorptiometry (DXA) of lumbar vertebrae, and the Z score was calculated to avoid bias of sex and age. Serum concentrations of ionized calcium (s Ca2+), 1,25-Dihydroxyvitamin D (s1, 25(OH)2D3) and osteocalcin (sOC) were measured at the same time.
RESULTS: In women with sarcoidosis only, sCa2+ and s1,25(OH)2D3 showed inverse correlations with Z score of BMD (r = 0.482, p < 0.05 and r = -0.635, p < 0.01, respectively), and s1,25(OH)2D3 showed a positive correlation with sOC (r = 0.658, p < 0.01). Multiple regression analysis showed that age and s1,25(OH)2D3 were the contributory factors to BMD in female patients. Such a significant correlation was not observed in men with sarcoidosis or controls.
CONCLUSIONS: 1,25(OH)2D3 seemed to be contributory to accelerated turnover of the bone and reduction of BMD in women with sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560127

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  5 in total

1.  Bone density is normal and does not change over 2 years in sarcoidosis.

Authors:  M J Bolland; M L Wilsher; A Grey; A M Horne; S Fenwick; G D Gamble; I R Reid
Journal:  Osteoporos Int       Date:  2014-08-30       Impact factor: 4.507

2.  Randomised controlled trial of vitamin D supplementation in sarcoidosis.

Authors:  Mark J Bolland; Margaret L Wilsher; Andrew Grey; Anne M Horne; Sheryl Fenwick; Greg D Gamble; Ian R Reid
Journal:  BMJ Open       Date:  2013-10-23       Impact factor: 2.692

3.  Bone Mineral Loss and Fracture in Sarcoidosis: A Systematic Review and Meta-Analysis.

Authors:  Wai Chung Yong; Sikarin Upala; Anawin Sanguankeo
Journal:  Arch Rheumatol       Date:  2018-09-05       Impact factor: 1.472

4.  Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients.

Authors:  Nathalie Saidenberg-Kermanac'h; Luca Semerano; Hilario Nunes; Danielle Sadoun; Xavier Guillot; Marouane Boubaya; Nicolas Naggara; Dominique Valeyre; Marie-Christophe Boissier
Journal:  Arthritis Res Ther       Date:  2014-03-24       Impact factor: 5.156

5.  Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.

Authors:  S Bours; F de Vries; J P W van den Bergh; A Lalmohamed; T P van Staa; H G M Leufkens; P P P Geusens; M Drent; N C Harvey
Journal:  Osteoporos Int       Date:  2015-12-02       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.